How much did Merus achieve in EBIT for the current year?
In the current year, Merus has achieved an EBIT of -199.73 M USD.
Merus EBIT 2024
Merus EBIT
-199.73 M USD
Ticker
MRUS
ISIN
NL0011606264
WKN
A2AKFX
In 2024, Merus's EBIT was -199.73 M USD, a 27.59% increase from the -156.55 M USD EBIT recorded in the previous year.
The Merus EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2029e | - |
| 2028e | 61.22 |
| 2027e | -160.23 |
| 2026e | -228.47 |
| 2025e | -232.41 |
| 2024e | -199.73 |
| 2023 | -156.55 |
| 2022 | -160.04 |
| 2021 | -89.98 |
| 2020 | -75.88 |
| 2019 | -56.86 |
| 2018 | -45.74 |
| 2017 | -38.64 |
| 2016 | -29.19 |
| 2015 | -20.66 |
| 2014 | -17.02 |
| 2013 | -13.15 |
Merus Revenue, EBIT, Net Income NL0011606264 · A2AKFX
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Merus, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Merus from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Merus’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Merus. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Merus’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Merus’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Merus’s growth potential.
Merus Revenue, EBIT and net profit per share
| Date | Merus Revenue | Merus EBIT | Merus Net Income |
|---|---|---|---|
| 2029e | 900.35 M undefined | 0 undefined | 368.97 M undefined |
| 2028e | 471.5 M undefined | 61.22 M undefined | 47.61 M undefined |
| 2027e | 299.78 M undefined | -160.23 M undefined | -94.15 M undefined |
| 2026e | 109.5 M undefined | -228.47 M undefined | -236.01 M undefined |
| 2025e | 56.83 M undefined | -232.41 M undefined | -252.5 M undefined |
| 2024e | 33.32 M undefined | -199.73 M undefined | -215.54 M undefined |
| 2023 | 43.95 M undefined | -156.55 M undefined | -154.94 M undefined |
| 2022 | 41.59 M undefined | -160.04 M undefined | -131.19 M undefined |
| 2021 | 49.11 M undefined | -89.98 M undefined | -66.82 M undefined |
| 2020 | 29.94 M undefined | -75.88 M undefined | -85.51 M undefined |
| 2019 | 31.13 M undefined | -56.86 M undefined | -55.15 M undefined |
| 2018 | 38.38 M undefined | -45.74 M undefined | -28.31 M undefined |
| 2017 | 24.71 M undefined | -38.64 M undefined | -73.05 M undefined |
| 2016 | 2.78 M undefined | -29.19 M undefined | -52.47 M undefined |
| 2015 | 2.19 M undefined | -20.66 M undefined | -25.72 M undefined |
| 2014 | 1.73 M undefined | -17.02 M undefined | -23.09 M undefined |
| 2013 | 740,000 undefined | -13.15 M undefined | -13.16 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2013 | 740,000 USD | -13.15 M USD | -13.16 M USD |
| 2014 | 1.73 M USD | -17.02 M USD | -23.09 M USD |
| 2015 | 2.19 M USD | -20.66 M USD | -25.72 M USD |
| 2016 | 2.78 M USD | -29.19 M USD | -52.47 M USD |
| 2017 | 24.71 M USD | -38.64 M USD | -73.05 M USD |
| 2018 | 38.38 M USD | -45.74 M USD | -28.31 M USD |
| 2019 | 31.13 M USD | -56.86 M USD | -55.15 M USD |
| 2020 | 29.94 M USD | -75.88 M USD | -85.51 M USD |
| 2021 | 49.11 M USD | -89.98 M USD | -66.82 M USD |
| 2022 | 41.59 M USD | -160.04 M USD | -131.19 M USD |
| 2023 | 43.95 M USD | -156.55 M USD | -154.94 M USD |
| 2024e | 33.32 M USD | -199.73 M USD | -215.54 M USD |
| 2025e | 56.83 M USD | -232.41 M USD | -252.5 M USD |
| 2026e | 109.5 M USD | -228.47 M USD | -236.01 M USD |
| 2027e | 299.78 M USD | -160.23 M USD | -94.15 M USD |
| 2028e | 471.5 M USD | 61.22 M USD | 47.61 M USD |
| 2029e | 900.35 M USD | 0 USD | 368.97 M USD |
Merus stock margins NL0011606264 · A2AKFX
The Merus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Merus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Merus.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Merus's sales revenue. A higher gross margin percentage indicates that the Merus retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Merus's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Merus's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Merus's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Merus. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Merus's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Merus Margin History
| Merus Gross margin | Merus Profit margin | Merus EBIT margin | Merus Profit margin |
|---|---|---|---|
| 2029e | 0 % | 0 % | 40.98 % |
| 2028e | 0 % | 12.98 % | 10.1 % |
| 2027e | 0 % | -53.45 % | -31.41 % |
| 2026e | 0 % | -208.65 % | -215.54 % |
| 2025e | 0 % | -408.98 % | -444.34 % |
| 2024e | 0 % | -599.43 % | -646.88 % |
| 2023 | 0 % | -356.22 % | -352.56 % |
| 2022 | 0 % | -384.8 % | -315.44 % |
| 2021 | 0 % | -183.22 % | -136.06 % |
| 2020 | 0 % | -253.44 % | -285.6 % |
| 2019 | 0 % | -182.65 % | -177.16 % |
| 2018 | 0 % | -119.18 % | -73.76 % |
| 2017 | 0 % | -156.37 % | -295.63 % |
| 2016 | 0 % | -1,050 % | -1,887.41 % |
| 2015 | 0 % | -943.38 % | -1,174.43 % |
| 2014 | 0 % | -983.82 % | -1,334.68 % |
| 2013 | 0 % | -1,777.03 % | -1,778.38 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2013 | 0 % | -1,777.03 % | -1,778.38 % |
| 2014 | 0 % | -983.82 % | -1,334.68 % |
| 2015 | 0 % | -943.38 % | -1,174.43 % |
| 2016 | 0 % | -1,050 % | -1,887.41 % |
| 2017 | 0 % | -156.37 % | -295.63 % |
| 2018 | 0 % | -119.18 % | -73.76 % |
| 2019 | 0 % | -182.65 % | -177.16 % |
| 2020 | 0 % | -253.44 % | -285.6 % |
| 2021 | 0 % | -183.22 % | -136.06 % |
| 2022 | 0 % | -384.8 % | -315.44 % |
| 2023 | 0 % | -356.22 % | -352.56 % |
| 2024e | 0 % | -599.43 % | -646.88 % |
| 2025e | 0 % | -408.98 % | -444.34 % |
| 2026e | 0 % | -208.65 % | -215.54 % |
| 2027e | 0 % | -53.45 % | -31.41 % |
| 2028e | 0 % | 12.98 % | 10.1 % |
| 2029e | 0 % | 0 % | 40.98 % |
Merus Aktienanalyse
What does Merus do?
Merus NV is a Dutch biotechnology company specialized in the development of innovative therapies for cancer and other serious diseases. The company was founded in 2003 by Ton Logtenberg and Piet Gros and is headquartered in Utrecht. Merus' business model is based on the development of bispecific antibodies, which can bind to two different target structures simultaneously. These antibodies can specifically attack and destroy tumor cells by minimizing their binding to healthy cells, providing Merus with a high potential for cancer therapy and other diseases. The company is divided into two main divisions: Merus BV and Merus US Inc. Merus BV specializes in the development of bispecific antibodies and operates its own manufacturing facility in Utrecht, while Merus US Inc. focuses on the clinical development of cancer immunotherapies. Merus offers a variety of products, including Bispecific Antibodies for Multiple Targets (BAMTs), Multi-specific Antibodies (MSAs), TrioBody platform, and Smart-chemotherapy platform. The BAMT program aims to develop bispecific antibodies that can bind to multiple target structures simultaneously, enhancing their effectiveness against tumor cells. The company's MSA products aim to introduce a bispecific antibody system with specialized drainage function to enhance the efficiency of cancer treatments. Merus' TrioBody platform represents a form of bispecific antibodies specifically tailored to cells in tumors, providing a higher efficacy in destroying tumor cells compared to conventional antibodies. Merus' Smart-Chemotherapy platform aims to increase the efficiency of chemotherapy drugs by delivering the medication specifically to tumor cells, maximizing its effect on tumor cells while minimizing its effect on normal cells. The company has entered into various partnerships and collaborations with other companies to advance its research and development in the field of cancer immunotherapy. In 2018, Merus signed an agreement with Incyte, granting Incyte the right to use Merus' bispecific antibody platform for cancer treatment. Additionally, Merus has formed strategic alliances with other biotechnology companies such as Jazz Pharmaceuticals and Loxo Oncology to further develop in various areas of cancer immunotherapy. Merus is committed to continue investing in research and development of its antibody technology to increase the effectiveness of cancer treatments and provide patients worldwide with new therapies to combat cancer. Merus ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Merus's EBIT
Merus's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Merus's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Merus's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Merus’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Merus stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Merus.
How has the EBIT of Merus developed in recent years?
The EBIT of Merus has increased by 27.586% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Merus?
The EBIT of Merus is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Merus pay?
Over the past 12 months, Merus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Merus is expected to pay a dividend of 0 USD.
What is the dividend yield of Merus?
The current dividend yield of Merus is .
When does Merus pay dividends?
Merus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Merus?
Merus paid dividends every year for the past 0 years.
What is the dividend of Merus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Merus located?
Merus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merus from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.
When did Merus pay the last dividend?
The last dividend was paid out on 9/13/2024.
What was the dividend of Merus in the year 2023?
In the year 2023, Merus distributed 0 USD as dividends.
In which currency does Merus pay out the dividend?
The dividends of Merus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Merus
Our stock analysis for Merus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
